MTOR and breast carcinoma: In a study, Zhou et al. [41] demonstrated that A. membranaceus inhibits proliferation in breast cancer cells by interfering with phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway.